[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑬ | Interview with Dr. Elena Rumyantseva Mathey, KOL for JUVELOOK
Dr. Elena Rumyantseva Mathey, a KOL for JUVELOOK who has built a robust body of clinical evidence across European practice, took the stage at a VAIM-hosted session during IMCAS World Congress 2026 to present six scientifically proven mechanisms of action for JUVELOOK, framing the product as "true rejuvenation, not just collagen stimulation." The enthusiasm was palpable—physicians from around the world gathered around her after the session, many lamenting that the product had not yet reached their markets. In an exclusive interview in Paris, Dr. Mathey elaborated on nodule safety through CMC-free formulation, clinical distinctions between JUVELOOK and JUVELOOK Volume indications, and compelling cases involving atrophic scars and rosacea patients. She also expressed her admiration for K-medical aesthetics, noting that "Korea has a culture of pursuing perfection—and that is something we should learn from."
#MedicalAestheticNews #IMCAS2026 #VAIM #JUVELOOK #JUVELOOKVolume #LENISNA #KMedicalAesthetics #DrElenaRumyantsevaMathey
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11240

Comments
Post a Comment